FMAQX | VMATX | FMAQX / VMATX | |
Total Expense Ratio | 0.89 | 0.09 | 989% |
Annual Report Gross Expense Ratio | 0.89 | 0.09 | 989% |
Fund Existence | 7 years | 27 years | - |
Gain YTD | -1.973 | -3.264 | 60% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 333M | 2.83B | 12% |
Annual Yield % from dividends | 2.88 | 3.61 | 80% |
Returns for 1 year | -0.77 | -3.46 | 22% |
Returns for 3 years | 4.32 | -1.27 | -340% |
Returns for 5 years | -6.78 | -12.85 | 53% |
Returns for 10 years | N/A | -8.09 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
THQ | 18.19 | 0.15 | +0.83% |
abrdn Healthcare Opportunities Fund | |||
XJH | 41.60 | 0.22 | +0.53% |
iShares ESG Select Scrn S&P Mid-Cap ETF | |||
CPAI | 36.97 | 0.02 | +0.05% |
Counterpoint Quantitative Equity ETF | |||
GVI | 106.60 | -0.15 | -0.14% |
iShares Intermediate Govt/Crdt Bd ETF | |||
OZEM | 25.15 | -0.13 | -0.51% |
Roundhill GLP-1 & Weight Loss ETF |